Metraipolis › archive › dc_11abc384ad04

Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasis — Europe PMC PMID:41958571

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41958571
DOI
10.3389/fmed.2026.1725638
License (as archived)
solo-consultazione
Archived
2026-11-03T22:08:06.563Z
SHA-256 of the archived text
5d282073baf28635767f3441a56270d647d75ad0552ded54110a79f70dd890cb
Stable URL of this page
https://metraipolis.com/documento/dc_11abc384ad04

How to cite

Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasis — Europe PMC PMID:41958571 — Europe PMC (en), https://europepmc.org/article/MED/41958571 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11abc384ad04 (Metraipolis archive dc_11abc384ad04, sha256 5d282073baf28635767f3441a56270d647d75ad0552ded54110a79f70dd890cb)
BibTeX
@misc{dc11abc384ad04,
  title = {Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasis — Europe PMC PMID:41958571},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41958571},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11abc384ad04; sha256 5d282073baf28635767f3441a56270d647d75ad0552ded54110a79f70dd890cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41958571. Agents can read the archived copy with the MCP tool read_document.